-
Je něco špatně v tomto záznamu ?
EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†
A. Horwich, M. Babjuk, J. Bellmunt, HM. Bruins, TM. De Reijke, M. De Santis, S. Gillessen, N. James, S. Maclennan, J. Palou, T. Powles, MJ. Ribal, SF. Shariat, T. Van Der Kwast, E. Xylinas, N. Agarwal, T. Arends, A. Bamias, A. Birtle, PC. Black,...
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Free Medical Journals
od 1996 do Před 1 rokem
Elsevier Open Access Journals
od 1990
Elsevier Open Archive Journals
od 1990 do Před 1 rokem
PubMed
31740927
DOI
10.1093/annonc/mdz296
Knihovny.cz E-zdroje
- MeSH
- delfská metoda MeSH
- konsensus * MeSH
- lékařská onkologie metody normy MeSH
- lidé MeSH
- mezinárodní spolupráce MeSH
- močový měchýř patologie MeSH
- nádory močového měchýře patologie terapie MeSH
- průzkumy a dotazníky MeSH
- směrnice pro lékařskou praxi jako téma * MeSH
- společnosti lékařské normy MeSH
- staging nádorů MeSH
- účast zainteresovaných stran MeSH
- urologie metody normy MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Evropa MeSH
BACKGROUND: Although guidelines exist for advanced and variant bladder cancer management, evidence is limited/conflicting in some areas and the optimal approach remains controversial. OBJECTIVE: To bring together a large multidisciplinary group of experts to develop consensus statements on controversial topics in bladder cancer management. DESIGN: A steering committee compiled proposed statements regarding advanced and variant bladder cancer management which were assessed by 113 experts in a Delphi survey. Statements not reaching consensus were reviewed; those prioritised were revised by a panel of 45 experts before voting during a consensus conference. SETTING: Online Delphi survey and consensus conference. PARTICIPANTS: The European Association of Urology (EAU), the European Society for Medical Oncology (ESMO), experts in bladder cancer management. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Statements were ranked by experts according to their level of agreement: 1-3 (disagree), 4-6 (equivocal), 7-9 (agree). A priori (level 1) consensus was defined as ≥70% agreement and ≤15% disagreement, or vice versa. In the Delphi survey, a second analysis was restricted to stakeholder group(s) considered to have adequate expertise relating to each statement (to achieve level 2 consensus). RESULTS AND LIMITATIONS: Overall, 116 statements were included in the Delphi survey. Of these, 33 (28%) statements achieved level 1 consensus and 49 (42%) statements achieved level 1 or 2 consensus. At the consensus conference, 22 of 27 (81%) statements achieved consensus. These consensus statements provide further guidance across a broad range of topics, including the management of variant histologies, the role/limitations of prognostic biomarkers in clinical decision making, bladder preservation strategies, modern radiotherapy techniques, the management of oligometastatic disease and the evolving role of checkpoint inhibitor therapy in metastatic disease. CONCLUSIONS: These consensus statements provide further guidance on controversial topics in advanced and variant bladder cancer management until a time where further evidence is available to guide our approach.
Academic Urology Unit University of Aberdeen Aberdeen UK
Barts Cancer Institute Queen Mary University of London London UK
Brighton and Sussex Medical School Brighton UK
Cancer Sciences Unit University of Southampton Southampton UK
Cancer Treatment Centre Sorlandet Hospital Kristiansand Norway
CRUK MRC Oxford Institute for Radiation Oncology University of Oxford Oxford UK
Department of Biomedical Sciences Humanitas University Milan
Department of Cancer Medicine Hôpital Saint Louis Paris
Department of Clinical Oncology Leiden University Medical Center Leiden
Department of Clinical Oncology The Royal Marsden NHS Foundation Trust London UK
Department of Imaging and Nuclear Medicine Royal Sussex County Hospital Brighton
Department of Medical Oncology and Hematology University Hospital Zürich Zürich Switzerland
Department of Medical Oncology Centre Georges François Leclerc Dijon France
Department of Medical Oncology Istituto Nazionale Tumori of Milan Milan Italy
Department of Medicine Memorial Sloan Kettering Cancer Center New York
Department of Medicine University of Melbourne Melbourne
Department of Nuclear Medicine Policlinico S Orsola University of Bologna Bologna Italy
Department of Nuclear Medicine Universitätsklinikum Essen Essen Germany
Department of Oncology Akershus University Hospital Lørenskog
Department of Oncology and Hemato oncology University of Milan Milan
Department of Oncology Hospital Universitario San Roque Canarias
Department of Oncology Rigshospitalet University Hospital of Copenhagen Copenhagen Denmark
Department of Pathology Erasmus Medical Center Rotterdam The Netherlands
Department of Pathology Tenon Hospital HUEP Paris
Department of Radiation Oncology Eberhard Karls University Tübingen Germany
Department of Radiation Oncology Europe Hospitals Brussels Brussels Belgium
Department of Radiation Oncology Gustave Roussy Institute Villejuif France
Department of Radiation Oncology Radboud University Medical Center Nijmegen The Netherlands
Department of Radiation Oncology University Hospital Ulm Ulm Germany
Department of Radiology and Nuclear Medicine Rijnstate Hospital Arnhem The Netherlands
Department of Radiology Copenhagen University Hospital Herlev and Gentofte Herlev Denmark
Department of Radiotherapy Institut Bergonié Bordeaux France
Department of Radiotherapy Oncology Ghent University Hospital Ghent Belgium
Department of Surgery Austin Health University of Melbourne Melbourne
Department of Surgical and Perioperative Sciences Urology and Andrology Umeå University Umeå Sweden
Department of Urology Aberdeen Royal Infirmary Aberdeen UK
Department of Urology Auckland City Hospital Auckland New Zealand
Department of Urology Bichat Claude Bernard Hospital Assistance Publique Hôpitaux de Paris Paris
Department of Urology Caritas St Josef Medical Center University of Regensburg Regensburg Germany
Department of Urology Centro Hospitalar São João Porto
Department of Urology Charité University Hospital Berlin Germany
Department of Urology Eberhard Karls University Tübingen Tübingen Germany
Department of Urology Erasmus University Medical Center Rotterdam The Netherlands
Department of Urology Fundació Puigvert Universitat Autònoma de Barcelona Barcelona Spain
Department of Urology Ghent University Hospital Ghent Belgium
Department of Urology Hospital Universitario Fundación de Alcorcón Madrid Spain
Department of Urology Inselspital Bern University Hospital Berne Switzerland
Department of Urology Karolinska Institutet Stockholm Sweden
Department of Urology Luzerner Kantonsspital Luzern Switzerland
Department of Urology Medical University of Vienna Vienna Austria
Department of Urology Medizinische Universität Graz Graz Austria
Department of Urology Pediatric Urology and Urologic Oncology Kliniken Essen Mitte Essen Germany
Department of Urology Radboud University Medical Center Nijmegen
Department of Urology Rechts der Isar Medical Center Technical University of Munich Munich Germany
Department of Urology Rigshospitalet Copenhagen University Hospital Copenhagen Denmark
Department of Urology Royal Surrey County Hospital Guildford UK
Department of Urology Ruhr University Bochum Marien Hospital Herne Germany
Department of Urology Saint John Emergency Clinical Hospital Bucharest Romania
Department of Urology Sorbonne Université GRC n°5 ONCOTYPE URO AP HP Hôpital Pitié Salpêtrière Paris
Department of Urology Tampere University Hospital Tampere Finland
Department of Urology University Hospital La Paz Madrid Spain
Department of Urology University Hospital of Turku Turku Finland
Department of Urology University Hospitals Leuven Leuven Belgium
Department of Urology University Medical Center Hamburg Eppendorf Hamburg
Department of Urology University Medical Center Utrecht Utrecht The Netherlands
Department of Urology University of California San Diego Pathology La Jolla USA
Department of Urology University of Texas Southwestern Medical Center Dallas USA
Department of Urology Urological Research Institute Milan
Department of Urology UWA Medical School University of Western Australia Perth Australia
Department of Urology Weill Cornell Medical College New York
Department of Urology Westmead Hospital University of Sydney Sydney Australia
Depatment of Urology 2nd Faculty of Medicine Hospital Motol Charles University Prague Czech Republic
Division of Cancer Sciences University of Manchester Manchester
Division of Oncology and Haematology Kantonsspital St Gallen St Gallen
Division of Radiotherapy and Imaging The Institute of Cancer Research London
Division of Radiotherapy IEO European Institute of Oncology IRCCS Milan Italy
Division of Urology IREC Cliniques Universitaires Saint Luc UCL Brussels Belgium
Division of Urology Molinette Hospital University of Studies of Torino Torino Italy
Eastern Health Clinical School Monash University Melbourne Australia
EAU Guidelines Office Arnhem The Netherlands
Emeritus Professor of Radiation Oncology Grenoble Alpes University Grenoble France
Emeritus Professor The Institute of Cancer Research London UK
Faculty of Medicine University of Oslo Oslo Norway
Harvard Medical School Boston USA
Hospices Civils de Lyon Service d'Imagerie Urinaire et Vasculaire Hôpital Edouard Herriot Lyon
Humanitas Research Hospital Milan Italy
Huntsman Cancer Institute University of Utah Salt Lake City USA
Icahn School of Medicine Mount Sinai Health System New York City USA
IMIM Hospital del Mar Medical Research Institute Barcelona Spain
Institute of Cancer and Genomic Sciences University of Birmingham Birmingham
Institute of Pathology Friedrich Alexander University Erlangen Nürnberg Erlangen Germany
Leeds Institute of Medical Research University of Leeds Leeds UK
Life and Health Sciences Research Institute School of Medicine University of Minho Braga Portugal
Medical Oncology Department 12 de Octubre University Hospital Madrid Spain
Molecular Imaging Program National Cancer Institute Bethesda USA
Monash University Melbourne Australia
Mount Vernon Centre for Cancer Treatment London UK
Paris Descartes University Paris France
Rosemere Cancer Centre Lancashire Teaching Hospitals Preston UK
Servicio de Urología Fundación Instituto Valenciano de Oncología Valencia Spain
Sorbonne University Paris France
The Christie NHS Foundation Trust Manchester UK
The Royal Free NHS Trust London
UMC Utrecht Cancer Center MS Oncologic Urology Utrecht The Netherlands
Universidad Fernando Pessoa Canarias Spain
Université de Lyon Université Lyon 1 Faculté de Médecine Lyon Est Lyon France
University Hospitals Birmingham NHS Foundation Trust Birmingham
University of Bern Bern Switzerland
Uro Oncology Unit Hospital Clinic University of Barcelona Barcelona Spain
Urology Department Canisius Wilhelmina Ziekenhuis Nijmegen Nijmegen The Netherlands
Urology Service Department of Urology Memorial Sloan Kettering Cancer Center New York USA
Vita Salute University San Raffaele Scientific Institute Milan Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20025517
- 003
- CZ-PrNML
- 005
- 20201222153936.0
- 007
- ta
- 008
- 201125s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/annonc/mdz296 $2 doi
- 035 __
- $a (PubMed)31740927
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Horwich, A $u Emeritus Professor, The Institute of Cancer Research, London, UK; Emeritus Professor, The Institute of Cancer Research, London, UK. Electronic address: clinicalguidelines@esmo.org.
- 245 10
- $a EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees† / $c A. Horwich, M. Babjuk, J. Bellmunt, HM. Bruins, TM. De Reijke, M. De Santis, S. Gillessen, N. James, S. Maclennan, J. Palou, T. Powles, MJ. Ribal, SF. Shariat, T. Van Der Kwast, E. Xylinas, N. Agarwal, T. Arends, A. Bamias, A. Birtle, PC. Black, BH. Bochner, M. Bolla, JL. Boormans, A. Bossi, A. Briganti, I. Brummelhuis, M. Burger, D. Castellano, R. Cathomas, A. Chiti, A. Choudhury, E. Compérat, S. Crabb, S. Culine, B. De Bari, W. DeBlok, PJL. De Visschere, K. Decaestecker, K. Dimitropoulos, JL. Dominguez-Escrig, S. Fanti, V. Fonteyne, M. Frydenberg, JJ. Futterer, G. Gakis, B. Geavlete, P. Gontero, B. Grubmüller, S. Hafeez, DE. Hansel, A. Hartmann, D. Hayne, AM. Henry, V. Hernandez, H. Herr, K. Herrmann, P. Hoskin, J. Huguet, BA. Jereczek-Fossa, R. Jones, AM. Kamat, V. Khoo, AE. Kiltie, S. Krege, S. Ladoire, PC. Lara, A. Leliveld, E. Linares-Espinós, V. Løgager, A. Lorch, Y. Loriot, R. Meijer, M. Carmen Mir, M. Moschini, H. Mostafid, AC. Müller, CR. Müller, J. N'Dow, A. Necchi, Y. Neuzillet, JR. Oddens, J. Oldenburg, S. Osanto, WJG. Oyen, L. Pacheco-Figueiredo, H. Pappot, MI. Patel, BR. Pieters, K. Plass, M. Remzi, M. Retz, J. Richenberg, M. Rink, F. Roghmann, JE. Rosenberg, M. Rouprêt, O. Rouvière, C. Salembier, A. Salminen, P. Sargos, S. Sengupta, A. Sherif, RJ. Smeenk, A. Smits, A. Stenzl, GN. Thalmann, B. Tombal, B. Turkbey, S. Vahr Lauridsen, R. Valdagni, AG. Van Der Heijden, H. Van Poppel, MD. Vartolomei, E. Veskimäe, A. Vilaseca, FA. Vives Rivera, T. Wiegel, P. Wiklund, A. Williams, R. Zigeuner, JA. Witjes,
- 520 9_
- $a BACKGROUND: Although guidelines exist for advanced and variant bladder cancer management, evidence is limited/conflicting in some areas and the optimal approach remains controversial. OBJECTIVE: To bring together a large multidisciplinary group of experts to develop consensus statements on controversial topics in bladder cancer management. DESIGN: A steering committee compiled proposed statements regarding advanced and variant bladder cancer management which were assessed by 113 experts in a Delphi survey. Statements not reaching consensus were reviewed; those prioritised were revised by a panel of 45 experts before voting during a consensus conference. SETTING: Online Delphi survey and consensus conference. PARTICIPANTS: The European Association of Urology (EAU), the European Society for Medical Oncology (ESMO), experts in bladder cancer management. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Statements were ranked by experts according to their level of agreement: 1-3 (disagree), 4-6 (equivocal), 7-9 (agree). A priori (level 1) consensus was defined as ≥70% agreement and ≤15% disagreement, or vice versa. In the Delphi survey, a second analysis was restricted to stakeholder group(s) considered to have adequate expertise relating to each statement (to achieve level 2 consensus). RESULTS AND LIMITATIONS: Overall, 116 statements were included in the Delphi survey. Of these, 33 (28%) statements achieved level 1 consensus and 49 (42%) statements achieved level 1 or 2 consensus. At the consensus conference, 22 of 27 (81%) statements achieved consensus. These consensus statements provide further guidance across a broad range of topics, including the management of variant histologies, the role/limitations of prognostic biomarkers in clinical decision making, bladder preservation strategies, modern radiotherapy techniques, the management of oligometastatic disease and the evolving role of checkpoint inhibitor therapy in metastatic disease. CONCLUSIONS: These consensus statements provide further guidance on controversial topics in advanced and variant bladder cancer management until a time where further evidence is available to guide our approach.
- 650 12
- $a konsensus $7 D032921
- 650 _2
- $a delfská metoda $7 D003697
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mezinárodní spolupráce $7 D007391
- 650 _2
- $a lékařská onkologie $x metody $x normy $7 D008495
- 650 _2
- $a staging nádorů $7 D009367
- 650 12
- $a směrnice pro lékařskou praxi jako téma $7 D017410
- 650 _2
- $a společnosti lékařské $x normy $7 D012955
- 650 _2
- $a účast zainteresovaných stran $7 D000073597
- 650 _2
- $a průzkumy a dotazníky $7 D011795
- 650 _2
- $a močový měchýř $x patologie $7 D001743
- 650 _2
- $a nádory močového měchýře $x patologie $x terapie $7 D001749
- 650 _2
- $a urologie $x metody $x normy $7 D014572
- 651 _2
- $a Evropa $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Babjuk, M $u Depatment of Urology, 2nd Faculty of Medicine, Hospital Motol, Charles University, Prague, Czech Republic; Department of Urology, Medical University of Vienna, Vienna, Austria.
- 700 1_
- $a Bellmunt, J $u IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain; Harvard Medical School, Boston, USA.
- 700 1_
- $a Bruins, H M $u Department of Urology, Radboud University Medical Center, Nijmegen.
- 700 1_
- $a De Reijke, T M $u Department of Urology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
- 700 1_
- $a De Santis, M $u Department of Urology, Medical University of Vienna, Vienna, Austria; Department of Urology, Charité University Hospital, Berlin, Germany.
- 700 1_
- $a Gillessen, S $u Division of Cancer Sciences, University of Manchester, Manchester; The Christie NHS Foundation Trust, Manchester, UK; Division of Oncology and Haematology, Kantonsspital St Gallen, St Gallen; University of Bern, Bern, Switzerland.
- 700 1_
- $a James, N $u University Hospitals Birmingham NHS Foundation Trust, Birmingham; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham.
- 700 1_
- $a Maclennan, S $u Academic Urology Unit, University of Aberdeen, Aberdeen, UK.
- 700 1_
- $a Palou, J $u Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.
- 700 1_
- $a Powles, T $u The Royal Free NHS Trust, London; Barts Cancer Institute, Queen Mary University of London, London, UK.
- 700 1_
- $a Ribal, M J $u Uro-Oncology Unit, Hospital Clinic, University of Barcelona, Barcelona, Spain.
- 700 1_
- $a Shariat, S F $u Depatment of Urology, 2nd Faculty of Medicine, Hospital Motol, Charles University, Prague, Czech Republic; Department of Urology, Medical University of Vienna, Vienna, Austria; Department of Urology, Weill Cornell Medical College, New York; Department of Urology, University of Texas Southwestern Medical Center, Dallas, USA; Institute for Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
- 700 1_
- $a Van Der Kwast, T $u Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands.
- 700 1_
- $a Xylinas, E $u Department of Urology, Bichat-Claude Bernard Hospital, Assistance Publique Hôpitaux de Paris, Paris; Paris Descartes University, Paris, France.
- 700 1_
- $a Agarwal, N $u Huntsman Cancer Institute, University of Utah (NCI-CCC), Salt Lake City, USA.
- 700 1_
- $a Arends, T $u Urology Department, Canisius-Wilhelmina Ziekenhuis Nijmegen, Nijmegen, The Netherlands.
- 700 1_
- $a Bamias, A $u 2nd Propaedeutic Dept of Internal Medicine, Medical School, National & Kapodistrian University of Athens, Athens, Greece.
- 700 1_
- $a Birtle, A $u Division of Cancer Sciences, University of Manchester, Manchester; Rosemere Cancer Centre, Lancashire Teaching Hospitals, Preston, UK.
- 700 1_
- $a Black, P C $u Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada.
- 700 1_
- $a Bochner, B H $u Department of Urology, Weill Cornell Medical College, New York; Urology Service, Department of Urology, Memorial Sloan Kettering Cancer Center, New York, USA.
- 700 1_
- $a Bolla, M $u Emeritus Professor of Radiation Oncology, Grenoble - Alpes University, Grenoble, France.
- 700 1_
- $a Boormans, J L $u Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands.
- 700 1_
- $a Bossi, A $u Department of Radiation Oncology, Gustave Roussy Institute, Villejuif, France.
- 700 1_
- $a Briganti, A $u Department of Urology, Urological Research Institute, Milan; Vita-Salute University, San Raffaele Scientific Institute, Milan, Italy.
- 700 1_
- $a Brummelhuis, I $u Department of Urology, Radboud University Medical Center, Nijmegen.
- 700 1_
- $a Burger, M $u Department of Urology, Caritas-St. Josef Medical Center, University of Regensburg, Regensburg, Germany.
- 700 1_
- $a Castellano, D $u Medical Oncology Department, 12 de Octubre University Hospital (CIBERONC), Madrid, Spain.
- 700 1_
- $a Cathomas, R $u Department Innere Medizin, Abteilung Onkologie und Hämatologie, Kantonsspital Graubünden, Chur, Switzerland.
- 700 1_
- $a Chiti, A $u Department of Biomedical Sciences, Humanitas University, Milan; Humanitas Research Hospital, Milan, Italy.
- 700 1_
- $a Choudhury, A $u Division of Cancer Sciences, University of Manchester, Manchester; The Christie NHS Foundation Trust, Manchester, UK.
- 700 1_
- $a Compérat, E $u Department of Pathology, Tenon Hospital, HUEP, Paris; Sorbonne University, Paris, France.
- 700 1_
- $a Crabb, S $u Cancer Sciences Unit, University of Southampton, Southampton, UK.
- 700 1_
- $a Culine, S $u Department of Cancer Medicine, Hôpital Saint Louis, Paris.
- 700 1_
- $a De Bari, B $u Radiation Oncology Department, Centre Hospitalier Régional Universitaire "Jean Minjoz" of Besançon, INSERM UMR 1098, Besançon, France; Radiation Oncology Department, Centre Hospitalier Universitaire Vaudois, Université de Lausanne, Lausanne, Switzerland.
- 700 1_
- $a DeBlok, W $u Department of Urology, University Medical Center Utrecht, Utrecht, The Netherlands.
- 700 1_
- $a De Visschere, P J L $u Department of Radiology and Nuclear Medicine, Division of Genitourinary Radiology and Mammography, Ghent University Hospital, Ghent.
- 700 1_
- $a Decaestecker, K $u Department of Urology, Ghent University Hospital, Ghent, Belgium.
- 700 1_
- $a Dimitropoulos, K $u Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK.
- 700 1_
- $a Dominguez-Escrig, J L $u Servicio de Urología, Fundación Instituto Valenciano de Oncología, Valencia, Spain.
- 700 1_
- $a Fanti, S $u Department of Nuclear Medicine, Policlinico S Orsola, University of Bologna, Bologna, Italy.
- 700 1_
- $a Fonteyne, V $u Department of Radiotherapy Oncology, Ghent University Hospital, Ghent, Belgium.
- 700 1_
- $a Frydenberg, M $u Department of Surgery, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia.
- 700 1_
- $a Futterer, J J $u Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
- 700 1_
- $a Gakis, G $u Department of Urology and Paediatric Urology, University Hospital of Würzburg, Julius-Maximillians University, Würzburg, Germany.
- 700 1_
- $a Geavlete, B $u Department of Urology, Saint John Emergency Clinical Hospital, Bucharest, Romania.
- 700 1_
- $a Gontero, P $u Division of Urology, Molinette Hospital, University of Studies of Torino, Torino, Italy.
- 700 1_
- $a Grubmüller, B $u Department of Urology, Medical University of Vienna, Vienna, Austria.
- 700 1_
- $a Hafeez, S $u Division of Radiotherapy and Imaging, The Institute of Cancer Research, London; Department of Clinical Oncology, The Royal Marsden NHS Foundation Trust, London, UK.
- 700 1_
- $a Hansel, D E $u Department of Urology, University of California, San Diego Pathology, La Jolla, USA.
- 700 1_
- $a Hartmann, A $u Institute of Pathology, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Erlangen, Germany.
- 700 1_
- $a Hayne, D $u Department of Urology, UWA Medical School, University of Western Australia, Perth, Australia.
- 700 1_
- $a Henry, A M $u Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
- 700 1_
- $a Hernandez, V $u Department of Urology, Hospital Universitario Fundación de Alcorcón, Madrid, Spain.
- 700 1_
- $a Herr, H $u Urology Service, Department of Urology, Memorial Sloan Kettering Cancer Center, New York, USA.
- 700 1_
- $a Herrmann, K $u Department of Nuclear Medicine, Universitätsklinikum Essen, Essen, Germany.
- 700 1_
- $a Hoskin, P $u Division of Cancer Sciences, University of Manchester, Manchester; The Christie NHS Foundation Trust, Manchester, UK; Mount Vernon Centre for Cancer Treatment, London, UK.
- 700 1_
- $a Huguet, J $u Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.
- 700 1_
- $a Jereczek-Fossa, B A $u Department of Oncology and Hemato-oncology, University of Milan, Milan; Division of Radiotherapy, IEO European Institute of Oncology, IRCCS, Milan, Italy.
- 700 1_
- $a Jones, R $u Institute of Cancer Sciences, College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
- 700 1_
- $a Kamat, A M $u Department of Urology - Division of Surgery, The University of Texas, MD Anderson Cancer Center, Houston, USA.
- 700 1_
- $a Khoo, V $u Division of Radiotherapy and Imaging, The Institute of Cancer Research, London; Department of Clinical Oncology, The Royal Marsden NHS Foundation Trust, London, UK; Department of Medicine, University of Melbourne, Melbourne; Monash University, Melbourne, Australia.
- 700 1_
- $a Kiltie, A E $u CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
- 700 1_
- $a Krege, S $u Department of Urology, Pediatric Urology and Urologic Oncology, Kliniken Essen-Mitte, Essen, Germany.
- 700 1_
- $a Ladoire, S $u Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France.
- 700 1_
- $a Lara, P C $u Department of Oncology, Hospital Universitario San Roque, Canarias; Universidad Fernando Pessoa, Canarias, Spain.
- 700 1_
- $a Leliveld, A $u Department of Urology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
- 700 1_
- $a Linares-Espinós, E $u Department of Urology, University Hospital La Paz, Madrid, Spain.
- 700 1_
- $a Løgager, V $u Department of Radiology, Copenhagen University Hospital Herlev and Gentofte, Herlev, Denmark.
- 700 1_
- $a Lorch, A $u Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland.
- 700 1_
- $a Loriot, Y $u Département de Médecine Oncologique, Gustave Roussy, INSERM U981, Université Paris-Sud, Université Paris-Saclay, Villejuif, France.
- 700 1_
- $a Meijer, R $u UMC Utrecht Cancer Center, MS Oncologic Urology, Utrecht, The Netherlands.
- 700 1_
- $a Carmen Mir, M $u Servicio de Urología, Fundación Instituto Valenciano de Oncología, Valencia, Spain.
- 700 1_
- $a Moschini, M $u Department of Urology, Luzerner Kantonsspital, Luzern, Switzerland.
- 700 1_
- $a Mostafid, H $u Department of Urology, Royal Surrey County Hospital, Guildford, UK.
- 700 1_
- $a Müller, A-C $u Department of Radiation Oncology, Eberhard Karls University, Tübingen, Germany.
- 700 1_
- $a Müller, C R $u Cancer Treatment Centre, Sorlandet Hospital, Kristiansand, Norway.
- 700 1_
- $a N'Dow, J $u Academic Urology Unit, University of Aberdeen, Aberdeen, UK; Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK.
- 700 1_
- $a Necchi, A $u Department of Medical Oncology, Istituto Nazionale Tumori of Milan, Milan, Italy.
- 700 1_
- $a Neuzillet, Y $u Department of Urology, Hospital Foch, University of Versailles-Saint-Quentin-en-Yvelines, Suresnes, France.
- 700 1_
- $a Oddens, J R $u Department of Urology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
- 700 1_
- $a Oldenburg, J $u Department of Oncology, Akershus University Hospital, Lørenskog; Faculty of Medicine, University of Oslo, Oslo, Norway.
- 700 1_
- $a Osanto, S $u Department of Clinical Oncology, Leiden University Medical Center, Leiden.
- 700 1_
- $a Oyen, W J G $u Department of Biomedical Sciences, Humanitas University, Milan; Humanitas Research Hospital, Milan, Italy; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Radiology and Nuclear Medicine, Rijnstate Hospital, Arnhem, The Netherlands.
- 700 1_
- $a Pacheco-Figueiredo, L $u Department of Urology, Centro Hospitalar São João, Porto; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
- 700 1_
- $a Pappot, H $u Department of Oncology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.
- 700 1_
- $a Patel, M I $u Department of Urology, Westmead Hospital, University of Sydney, Sydney, Australia.
- 700 1_
- $a Pieters, B R $u Department of Radiation Oncology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam.
- 700 1_
- $a Plass, K $u EAU Guidelines Office, Arnhem, The Netherlands.
- 700 1_
- $a Remzi, M $u Department of Urology, Medical University of Vienna, Vienna, Austria.
- 700 1_
- $a Retz, M $u Department of Urology, Rechts der Isar Medical Center, Technical University of Munich, Munich, Germany.
- 700 1_
- $a Richenberg, J $u Department of Imaging and Nuclear Medicine, Royal Sussex County Hospital, Brighton; Brighton and Sussex Medical School, Brighton, UK.
- 700 1_
- $a Rink, M $u Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg.
- 700 1_
- $a Roghmann, F $u Department of Urology, Ruhr-University Bochum, Marien Hospital, Herne, Germany.
- 700 1_
- $a Rosenberg, J E $u Department of Medicine, Memorial Sloan Kettering Cancer Center, New York; Weill Cornell Medical College, New York, USA.
- 700 1_
- $a Rouprêt, M $u Department of Urology, Sorbonne Université, GRC n°5, ONCOTYPE-URO, AP-HP, Hôpital Pitié-Salpêtrière, Paris.
- 700 1_
- $a Rouvière, O $u Hospices Civils de Lyon, Service d'Imagerie Urinaire et Vasculaire, Hôpital Edouard Herriot, Lyon; Université de Lyon, Université Lyon 1, Faculté de Médecine Lyon Est, Lyon, France.
- 700 1_
- $a Salembier, C $u Department of Radiation Oncology, Europe Hospitals Brussels, Brussels, Belgium.
- 700 1_
- $a Salminen, A $u Department of Urology, University Hospital of Turku, Turku, Finland.
- 700 1_
- $a Sargos, P $u Department of Radiotherapy, Institut Bergonié, Bordeaux, France.
- 700 1_
- $a Sengupta, S $u Department of Surgery, Austin Health, University of Melbourne, Melbourne; Eastern Health Clinical School, Monash University, Melbourne, Australia.
- 700 1_
- $a Sherif, A $u Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden.
- 700 1_
- $a Smeenk, R J $u Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
- 700 1_
- $a Smits, A $u Department of Urology, Radboud University Medical Center, Nijmegen.
- 700 1_
- $a Stenzl, A $u Department of Urology, Eberhard Karls University Tübingen, Tübingen, Germany.
- 700 1_
- $a Thalmann, G N $u Department of Urology, Inselspital, Bern University Hospital, Berne, Switzerland.
- 700 1_
- $a Tombal, B $u Division of Urology, IREC, Cliniques Universitaires Saint Luc, UCL, Brussels, Belgium.
- 700 1_
- $a Turkbey, B $u Molecular Imaging Program, National Cancer Institute, Bethesda, USA.
- 700 1_
- $a Vahr Lauridsen, S $u Department of Urology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
- 700 1_
- $a Valdagni, R $u Department of Oncology and Hemato-oncology, Università degli Studi di Milano, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
- 700 1_
- $a Van Der Heijden, A G $u Department of Urology, Radboud University Medical Center, Nijmegen.
- 700 1_
- $a Van Poppel, H $u Department of Urology, University Hospitals Leuven, Leuven, Belgium.
- 700 1_
- $a Vartolomei, M D $u Department of Urology, Medical University of Vienna, Vienna, Austria; Department of Cell and Molecular Biology, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Targu Mures, Romania.
- 700 1_
- $a Veskimäe, E $u Department of Urology, Tampere University Hospital, Tampere, Finland.
- 700 1_
- $a Vilaseca, A $u Uro-Oncology Unit, Hospital Clinic, University of Barcelona, Barcelona, Spain.
- 700 1_
- $a Vives Rivera, F A $u Clinica HematoOncologica Bonadona Prevenir, Universidad Metropolitana, Clinica Club de Leones, Barranquilla, Colombia.
- 700 1_
- $a Wiegel, T $u Department of Radiation Oncology, University Hospital Ulm, Ulm, Germany.
- 700 1_
- $a Wiklund, P $u Icahn School of Medicine, Mount Sinai Health System, New York City, USA; Department of Urology, Karolinska Institutet, Stockholm, Sweden.
- 700 1_
- $a Williams, A $u Department of Urology, Auckland City Hospital, Auckland, New Zealand.
- 700 1_
- $a Zigeuner, R $u Department of Urology, Medizinische Universität Graz, Graz, Austria.
- 700 1_
- $a Witjes, J A $u Department of Urology, Radboud University Medical Center, Nijmegen.
- 773 0_
- $w MED00000432 $t Annals of oncology : official journal of the European Society for Medical Oncology $x 1569-8041 $g Roč. 30, č. 11 (2019), s. 1697-1727
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31740927 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222153930 $b ABA008
- 999 __
- $a ok $b bmc $g 1599662 $s 1116203
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 30 $c 11 $d 1697-1727 $e 20191101 $i 1569-8041 $m Annals of oncology $n Ann Oncol $x MED00000432
- LZP __
- $a Pubmed-20201125
